The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming

Metastasis is the major cause of death in cancer patients, yet the genetic and epigenetic programs that drive metastasis are poorly understood. Here, we report an epigenetic reprogramming pathway that is required for breast cancer metastasis. Concerted differential DNA methylation is initiated by th...

Full description

Bibliographic Details
Main Authors: Stéphanie Cunha, Yi-Chun Lin, Elizabeth A. Goossen, Christa I. DeVette, Mark R. Albertella, Stuart Thomson, Mark J. Mulvihill, Alana L. Welm
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124713007559
_version_ 1819152650801774592
author Stéphanie Cunha
Yi-Chun Lin
Elizabeth A. Goossen
Christa I. DeVette
Mark R. Albertella
Stuart Thomson
Mark J. Mulvihill
Alana L. Welm
author_facet Stéphanie Cunha
Yi-Chun Lin
Elizabeth A. Goossen
Christa I. DeVette
Mark R. Albertella
Stuart Thomson
Mark J. Mulvihill
Alana L. Welm
author_sort Stéphanie Cunha
collection DOAJ
description Metastasis is the major cause of death in cancer patients, yet the genetic and epigenetic programs that drive metastasis are poorly understood. Here, we report an epigenetic reprogramming pathway that is required for breast cancer metastasis. Concerted differential DNA methylation is initiated by the activation of the RON receptor tyrosine kinase by its ligand, macrophage stimulating protein (MSP). Through PI3K signaling, RON/MSP promotes expression of the G:T mismatch-specific thymine glycosylase MBD4. RON/MSP and MBD4-dependent aberrant DNA methylation results in the misregulation of a specific set of genes. Knockdown of MBD4 reverses methylation at these specific loci and blocks metastasis. We also show that the MBD4 glycosylase catalytic residue is required for RON/MSP-driven metastasis. Analysis of human breast cancers revealed that this epigenetic program is significantly associated with poor clinical outcome. Furthermore, inhibition of Ron kinase activity with a pharmacological agent blocks metastasis of patient-derived breast tumor grafts in vivo.
first_indexed 2024-12-22T14:52:40Z
format Article
id doaj.art-c5c460c2ffbb46b78a441db65573d121
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-22T14:52:40Z
publishDate 2014-01-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-c5c460c2ffbb46b78a441db65573d1212022-12-21T18:22:17ZengElsevierCell Reports2211-12472014-01-016114115410.1016/j.celrep.2013.12.010The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation ReprogrammingStéphanie Cunha0Yi-Chun Lin1Elizabeth A. Goossen2Christa I. DeVette3Mark R. Albertella4Stuart Thomson5Mark J. Mulvihill6Alana L. Welm7Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USADepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USADepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USADepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USAOSI/Astellas, Bioscience Park Drive, Farmingdale, NY 11735, USAOSI/Astellas, Bioscience Park Drive, Farmingdale, NY 11735, USAOSI/Astellas, Bioscience Park Drive, Farmingdale, NY 11735, USADepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, USAMetastasis is the major cause of death in cancer patients, yet the genetic and epigenetic programs that drive metastasis are poorly understood. Here, we report an epigenetic reprogramming pathway that is required for breast cancer metastasis. Concerted differential DNA methylation is initiated by the activation of the RON receptor tyrosine kinase by its ligand, macrophage stimulating protein (MSP). Through PI3K signaling, RON/MSP promotes expression of the G:T mismatch-specific thymine glycosylase MBD4. RON/MSP and MBD4-dependent aberrant DNA methylation results in the misregulation of a specific set of genes. Knockdown of MBD4 reverses methylation at these specific loci and blocks metastasis. We also show that the MBD4 glycosylase catalytic residue is required for RON/MSP-driven metastasis. Analysis of human breast cancers revealed that this epigenetic program is significantly associated with poor clinical outcome. Furthermore, inhibition of Ron kinase activity with a pharmacological agent blocks metastasis of patient-derived breast tumor grafts in vivo.http://www.sciencedirect.com/science/article/pii/S2211124713007559
spellingShingle Stéphanie Cunha
Yi-Chun Lin
Elizabeth A. Goossen
Christa I. DeVette
Mark R. Albertella
Stuart Thomson
Mark J. Mulvihill
Alana L. Welm
The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
Cell Reports
title The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
title_full The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
title_fullStr The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
title_full_unstemmed The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
title_short The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming
title_sort ron receptor tyrosine kinase promotes metastasis by triggering mbd4 dependent dna methylation reprogramming
url http://www.sciencedirect.com/science/article/pii/S2211124713007559
work_keys_str_mv AT stephaniecunha theronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT yichunlin theronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT elizabethagoossen theronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT christaidevette theronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT markralbertella theronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT stuartthomson theronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT markjmulvihill theronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT alanalwelm theronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT stephaniecunha ronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT yichunlin ronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT elizabethagoossen ronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT christaidevette ronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT markralbertella ronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT stuartthomson ronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT markjmulvihill ronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming
AT alanalwelm ronreceptortyrosinekinasepromotesmetastasisbytriggeringmbd4dependentdnamethylationreprogramming